ImmunoGen, Inc.

Legal & General Group Plc

Report date

12/31/2023

Quarter

2023 Q4

Filed

5/29/2025

Shares

235,326

Value ($000)

6,977

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	5/29/2025	6,977	0.0%	235,326	12/31/2023
2023 Q3	11/14/2023	3,405	0.0%	214,575	9/30/2023
2023 Q2	8/14/2023	4,011	0.0%	212,549	6/30/2023
2023 Q1	5/15/2023	355	0.0%	92,485	3/31/2023
2022 Q4	2/14/2023	428	0.0%	86,191	12/31/2022
2022 Q3	11/14/2022	406	0.0%	84,955	9/30/2022
2022 Q2	8/22/2022	353	0.0%	78,492	6/30/2022
2022 Q1	5/16/2022	380	0.0%	79,880	3/31/2022
2021 Q4	2/14/2022	579	0.0%	78,043	12/31/2021
2021 Q3	11/15/2021	428	0.0%	75,610	9/30/2021
2021 Q2	8/12/2021	245	0.0%	37,129	6/30/2021
2021 Q1	5/17/2021	300	0.0%	37,077	3/31/2021
2020 Q4	2/12/2021	214	0.0%	33,193	12/31/2020
2020 Q3	11/13/2020	133	0.0%	36,831	9/30/2020
2020 Q2	8/14/2020	205	0.0%	44,519	6/30/2020
2020 Q1	5/14/2020	150	0.0%	44,016	3/31/2020
2019 Q4	2/13/2020	201	0.0%	39,420	12/31/2019